EHA Library - The official digital education library of European Hematology Association (EHA)

BONE MARROW STROMAL CELLS MAY HAVE GENETIC ABERRATIONS AND ARE CAPABLE TO GAIN THEM IN A CULTURE.
Author(s):
Ildar Barkhatov
,
Ildar Barkhatov
Affiliations:
R.M. Gorbacheva Memorial Institute of Children Oncology, Hematology and Transplantation,FIRST PAVLOV SAINT PETERSBURG STATE MEDICAL UNIVERSITY,St.Petersburg,Russian Federation
Nikolai Tsvetkov
,
Nikolai Tsvetkov
Affiliations:
R.M. Gorbacheva Memorial Institute of Children Oncology, Hematology and Transplantation,FIRST PAVLOV SAINT PETERSBURG STATE MEDICAL UNIVERSITY,St.Petersburg,Russian Federation
Daniil Ershov
,
Daniil Ershov
Affiliations:
R.M. Gorbacheva Memorial Institute of Children Oncology, Hematology and Transplantation,FIRST PAVLOV SAINT PETERSBURG STATE MEDICAL UNIVERSITY,St.Petersburg,Russian Federation
Tatiana Gindina
,
Tatiana Gindina
Affiliations:
R.M. Gorbacheva Memorial Institute of Children Oncology, Hematology and Transplantation,FIRST PAVLOV SAINT PETERSBURG STATE MEDICAL UNIVERSITY,St.Petersburg,Russian Federation
Alena Shakirova
,
Alena Shakirova
Affiliations:
R.M. Gorbacheva Memorial Institute of Children Oncology, Hematology and Transplantation,FIRST PAVLOV SAINT PETERSBURG STATE MEDICAL UNIVERSITY,St.Petersburg,Russian Federation
Marina Nikolaeva
,
Marina Nikolaeva
Affiliations:
R.M. Gorbacheva Memorial Institute of Children Oncology, Hematology and Transplantation,FIRST PAVLOV SAINT PETERSBURG STATE MEDICAL UNIVERSITY,St.Petersburg,Russian Federation
Alisa Potter
,
Alisa Potter
Affiliations:
R.M. Gorbacheva Memorial Institute of Children Oncology, Hematology and Transplantation,FIRST PAVLOV SAINT PETERSBURG STATE MEDICAL UNIVERSITY,St.Petersburg,Russian Federation
Ludmila Zubarovskaya
,
Ludmila Zubarovskaya
Affiliations:
R.M. Gorbacheva Memorial Institute of Children Oncology, Hematology and Transplantation,FIRST PAVLOV SAINT PETERSBURG STATE MEDICAL UNIVERSITY,St.Petersburg,Russian Federation
Boris Afanasyev
Boris Afanasyev
Affiliations:
R.M. Gorbacheva Memorial Institute of Children Oncology, Hematology and Transplantation,FIRST PAVLOV SAINT PETERSBURG STATE MEDICAL UNIVERSITY,St.Petersburg,Russian Federation
(Abstract release date: 05/18/17) EHA Library. Barkhatov I. 05/18/17; 182567; PB1853
Dr. Ildar Barkhatov
Dr. Ildar Barkhatov
Contributions
PDF Abstract
Abstract

Abstract: PB1853

Type: Publication Only

Background
Stromal microenvironment posses a key role in the regulation of both normal hematopoiesis and its reconstitution after hematopoietic stem cell transplantation (HSCT). Recent data supports the idea that bone marrow stromal cells (BMSC) also have genetic aberrations and may tightly involved in the pathogenesis of HSCT complications. These findings justify the need for more detailed study of genetic aberrations in BMSC.

Aims
The aim of this study was to evaluate genetic aberrations in BMSC and check the ability to gain them in coculture system.

Methods
The interaction of BMSC with hematopoietic tumor cell lines bearing specific genetic aberrations (BCR-ABL fusion transcript for K-562 and JAK2 V617F mutation for Uke-1 cell line) was investigated in stromal cells harvested from 17 patients and 8 healthy donors. We performed cultivation of BMSC monolayer and tumor cells suspension using semipermeable membrane plates inserts with different pore size (0,4 μm and 3,0 μm) in order to exclude direct cell-to-cell contact. We looked also for existing specific genetic aberrations (point mutations and fusion transcripts) in BMSC of patients with the respective aberration in their leukemic clone. For this purpose we used both karyotyping (7 patients) and RQ-PCR method. BMSC were examined by flow cytometry to evaluate the possible contamination with cells of hematopoietic lineage.

Results
We investigated the BMSC karyotype in seven patients and only one case led us to a remarkable finding. The clonal chromosomal rearrangement t(1;7) was detected in 25% of BMSC metaphases. Interestingly, this aberration was never detected in patient’s leukemic cells.

We also examined BMSC from leukemia patients bearing recurrent genetic abnormalities and in one case the leukemia-specific marker was detected by RQ-PCR - we observed expression of ETV6-RUNX1 gene (≈0,02%) in BMSC by patient with t(12;21) acute lymphoblastic leukemia. At the moment of BMSC culture initiation ETV6-RUNX1 expression in patient’s bone marrow was detected at high level (ETV6-RUNX1/ABL*100=321%). Before carrying out RNA extraction BMSC were harvested after the second passage and no contamination with CD45+/CD34+ cells by flow cytometry was observed (50,000 events collected from the sample). When BMSCs and Uke-1 cell line were cocultured by using of 3,0 μm pore culture dishes inserts, the BMSC population gained the Jak2V617F mutation (allele burden ≈ 30,39%). We reproduced similar experiments with the K-562 cell line and got similar results - CD45+ cells were also detected in BMSC population (≈ 30%). Moreover we detected CD45+ non-cellular particles by flow cytometry analysis. Implying K-562 cells are not likely to cross the semipermeable membrane (3,0 μm pores versus 20,0 μm cells as measured during microscopy). Besides BCR-ABL gene expression in BMSC was detected by RQ-PCR (BCR-ABL/ABL*100=19%). We repeated same test with 0,4 μm pore inserts and without them in order to check implication of cell-to-cell interaction. We didn’t obtain any similar results with smaller pores, but the fusion transcript was detected in CD45- BMSC population when these two cell populations weren’t devided. Both findings point out at possible horizontal gene transfer mediated by membrane vesicles larger than 0,4 μm and direct whole cell fusion.

Conclusion
Our data stands for the existence of horizontal gene transfer between leukemic clone and BMSC. This process seems to be mediated by membrane vesicles larger than 0,4 μm in size, though cell fusion can also take place. We also confirmed the fact BMSCs can bear clonal genetic rearrangements which are not specific to tumor cell populations. These findings show tight interaction between tumor and microenvironment cells and can partly explain nature of PCR-based MRD persistence in complete remission.

Session topic: 23. Hematopoiesis, stem cells and microenvironment

Keyword(s): Chromosomal abnormality, Bone marrow stroma

Abstract: PB1853

Type: Publication Only

Background
Stromal microenvironment posses a key role in the regulation of both normal hematopoiesis and its reconstitution after hematopoietic stem cell transplantation (HSCT). Recent data supports the idea that bone marrow stromal cells (BMSC) also have genetic aberrations and may tightly involved in the pathogenesis of HSCT complications. These findings justify the need for more detailed study of genetic aberrations in BMSC.

Aims
The aim of this study was to evaluate genetic aberrations in BMSC and check the ability to gain them in coculture system.

Methods
The interaction of BMSC with hematopoietic tumor cell lines bearing specific genetic aberrations (BCR-ABL fusion transcript for K-562 and JAK2 V617F mutation for Uke-1 cell line) was investigated in stromal cells harvested from 17 patients and 8 healthy donors. We performed cultivation of BMSC monolayer and tumor cells suspension using semipermeable membrane plates inserts with different pore size (0,4 μm and 3,0 μm) in order to exclude direct cell-to-cell contact. We looked also for existing specific genetic aberrations (point mutations and fusion transcripts) in BMSC of patients with the respective aberration in their leukemic clone. For this purpose we used both karyotyping (7 patients) and RQ-PCR method. BMSC were examined by flow cytometry to evaluate the possible contamination with cells of hematopoietic lineage.

Results
We investigated the BMSC karyotype in seven patients and only one case led us to a remarkable finding. The clonal chromosomal rearrangement t(1;7) was detected in 25% of BMSC metaphases. Interestingly, this aberration was never detected in patient’s leukemic cells.

We also examined BMSC from leukemia patients bearing recurrent genetic abnormalities and in one case the leukemia-specific marker was detected by RQ-PCR - we observed expression of ETV6-RUNX1 gene (≈0,02%) in BMSC by patient with t(12;21) acute lymphoblastic leukemia. At the moment of BMSC culture initiation ETV6-RUNX1 expression in patient’s bone marrow was detected at high level (ETV6-RUNX1/ABL*100=321%). Before carrying out RNA extraction BMSC were harvested after the second passage and no contamination with CD45+/CD34+ cells by flow cytometry was observed (50,000 events collected from the sample). When BMSCs and Uke-1 cell line were cocultured by using of 3,0 μm pore culture dishes inserts, the BMSC population gained the Jak2V617F mutation (allele burden ≈ 30,39%). We reproduced similar experiments with the K-562 cell line and got similar results - CD45+ cells were also detected in BMSC population (≈ 30%). Moreover we detected CD45+ non-cellular particles by flow cytometry analysis. Implying K-562 cells are not likely to cross the semipermeable membrane (3,0 μm pores versus 20,0 μm cells as measured during microscopy). Besides BCR-ABL gene expression in BMSC was detected by RQ-PCR (BCR-ABL/ABL*100=19%). We repeated same test with 0,4 μm pore inserts and without them in order to check implication of cell-to-cell interaction. We didn’t obtain any similar results with smaller pores, but the fusion transcript was detected in CD45- BMSC population when these two cell populations weren’t devided. Both findings point out at possible horizontal gene transfer mediated by membrane vesicles larger than 0,4 μm and direct whole cell fusion.

Conclusion
Our data stands for the existence of horizontal gene transfer between leukemic clone and BMSC. This process seems to be mediated by membrane vesicles larger than 0,4 μm in size, though cell fusion can also take place. We also confirmed the fact BMSCs can bear clonal genetic rearrangements which are not specific to tumor cell populations. These findings show tight interaction between tumor and microenvironment cells and can partly explain nature of PCR-based MRD persistence in complete remission.

Session topic: 23. Hematopoiesis, stem cells and microenvironment

Keyword(s): Chromosomal abnormality, Bone marrow stroma

Premium Sponsors

What's new at EHA

Browse the open-source material from EHA past Congresses and meetings.

References

EHA Terms & Conditions
2025 ©
European Hematology Association
USER TERMS AND CONDITIONS / PRIVACY POLICY
(Amended according to GDPR)

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies